240401-22-3

Basic information

• Product Name: 4-CYANOPIPERIDINE HCL
• Synonyms: 4-CYANOPIPERIDINE HCL;4-Cyanopiperidine hydrochloride;4-Piperidinecarbonitrile hydrochloride(1:1)
• CAS NO: 240401-22-3
• Molecular Formula: C₆H₁₀N₂*ClH
• Molecular Weight: 146.62
• Mol File: 240401-22-3.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 4-CYANOPIPERIDINE HCL(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CYANOPIPERIDINE HCL(240401-22-3)
• EPA Substance Registry System: 4-CYANOPIPERIDINE HCL(240401-22-3)

Safety Data

• RIDADR: UN2811
• Hazardous Substances Data: 240401-22-3(Hazardous Substances Data)

Usage

Uses

Piperidine-4-carbonitrile hydrochloride is a useful research chemical.

Upstream product

• 91419-52-2 1-tert-butoxycarbonyl-4-cyanopiperidine 
• 4395-98-6 4-cyanopiperidine 
• 39546-32-2 4-carboxamidopiperidine 
• 872-50-4 1-methyl-pyrrolidin-2-one 
• 178308-63-9 1-Chloro-4-(3-chloro-4-methoxybenzyl)amino-6-cyanophthalazine 

Downstream Products

• 91419-52-2 1-tert-butoxycarbonyl-4-cyanopiperidine 
• 1257301-10-2 2-methylpropyl 2-(4-{4-[(4-cyanopiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}phenyl)-1H-imidazole-1-carboxylate 

Relevant articles and documents

AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS

The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the treatment or prevention of various diseases, conditions or disorders.

PIPERIDINE OR PIPERAZINE LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

The present invention relates to piperidine or piperazine linked imidazole and triazole derivatives, compositions comprising said compounds, alone or in combination with other drugs, and methods of using the compounds for improving the pharmacokinetics of a drug. The compounds of the invention are useful in human and veterinary medicine for inhbiting CYP3A4 and for improving the pharmacokinetics of a therapeutic compound that is metabolized by CYP3A4.

PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER

The present invention relates to compounds of Formula (I) and to their pharmaceutical compositions, and to their methods of use. These compounds provide a treatment for myeloproliferative disorders and cancer.